Evaluation and validation of potency testing method for live rubella virus vaccine

被引:0
|
作者
Wang, DY [1 ]
Yeh, SY [1 ]
Chou, CP [1 ]
Cheng, HF [1 ]
Hsieh, JT [1 ]
Lin, CP [1 ]
机构
[1] Execut Yuan, Dept Hlth, Div Pharmacobiol, Natl Labs Foods & Drugs, Taipei, Taiwan
关键词
cytopathic effect; live rubella vaccine; accuracy; precision and validation;
D O I
暂无
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The potency of live rubella virus vaccine is usually determined by the microtitration method using in vitro cytopathic effect (CPE) with rabbit kidney epithelial (RK-13) cell culture. However, it is difficult to identify the rubella viral CPE through microscopic examination. Therefore, developing a validated and accurate method for potency determination is important for the laboratories of the government and vaccine manufacturers to ensure the effectiveness of rubella vaccination. In this study, we evaluated different culture conditions of RK-13 cells for the potency test of live rubella virus vaccine. We found that the RK-13 cells with the initial plating number of 13,000 per well of 96-well cell culture plate, supplied with 2% fetal bovine serum (FBS) could form and maintain a normal monolayer for 14 days when incubated at 33 degreesC. In addition. our results showed that the rubella viral CPEs are developed faster and simpler under 2% of serum concentration and at 33 degreesC. The results of validation analysis finally confirmed that the culture condition with plating number of 13,000 cells/well, 2% of serum concentration, and 33 degreesC incubating temperature achieve the most accurate and precise results for the CPE potency test of live rubella virus vaccine.
引用
收藏
页码:183 / 190
页数:8
相关论文
共 50 条
  • [1] POTENCY TESTING OF LIVE MEASLES VACCINE
    MEYER, HM
    ROGERS, NG
    DOUGLAS, RD
    BROOKS, BE
    AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1962, 103 (03): : 457 - &
  • [2] LIVE RUBELLA VIRUS VACCINE IN TUBERCULOUS CHILDREN
    BERKOVICH, S
    STEINER, P
    STEINER, M
    AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1969, 118 (02): : 252 - +
  • [3] USE OF MICE FOR POTENCY TESTING OF MODIFIED LIVE-VIRUS RABIES VACCINE
    DEAN, DJ
    THOMPSON, WR
    SHERMAN, I
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 1963, 24 (100) : 614 - &
  • [4] Robustness testing of live attenuated rubella vaccine potency assay using fractional factorial design of experiments
    Kutle, Leonida
    Pavlovic, Nediljko
    Dorotic, Marko
    Zadro, Ivana
    Kapustic, Marijana
    Halassy, Beata
    VACCINE, 2010, 28 (33) : 5497 - 5502
  • [5] EVALUATION OF A LIVE ATTENUATED RUBELLA-VIRUS VACCINE (HPV-77)
    HOWARD, P
    LOEHR, A
    RILEY, HD
    SOUTHERN MEDICAL JOURNAL, 1968, 61 (12) : 1351 - &
  • [6] EXPERIMENTAL LIVE ATTENUATED RUBELLA VIRUS VACCINE - CLINICAL EVALUATION OF CENDEHILL STRAIN
    PRINZIE, A
    HUYGELEN, C
    GOLD, J
    FARQUHAR, J
    MCKEE, J
    AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1969, 118 (02): : 172 - &
  • [7] Potency testing of a live, genetically attenuated vaccine for salmonids
    Marsden, MJ
    Vaughan, LM
    Fitzpatrick, RM
    Foster, TJ
    Secombes, CJ
    VACCINE, 1998, 16 (11-12) : 1087 - 1094
  • [8] CLINICAL TRIAL OF AN EXPERIMENTAL LIVE ATTENUATED RUBELLA VIRUS VACCINE
    MEYER, HM
    PARKMAN, PD
    PANOS, TC
    JOURNAL OF PEDIATRICS, 1966, 69 (5P2): : 893 - +
  • [9] TRIALS WITH A LIVE ATTENUATED RUBELLA VIRUS VACCINE, CENDEHILL STRAIN
    GRANT, L
    BELLE, EA
    PROVAN, G
    KING, SD
    SIGEL, MM
    JOURNAL OF HYGIENE-CAMBRIDGE, 1970, 68 (03): : 505 - +
  • [10] CURRENT CONCEPTS - LIVE ATTENUATED RUBELLA-VIRUS VACCINE
    HILLEMAN, MR
    BUYNAK, EB
    WEIBEL, RE
    STOKES, J
    NEW ENGLAND JOURNAL OF MEDICINE, 1968, 279 (06): : 300 - &